{"organizations": [], "uuid": "777d49bed415866ba6af6d006c1388ce27360177", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.afr.com", "main_image": "http://www.afr.com/content/dam/images/g/i/2/e/u/n/image.related.afrArticleLead.620x365.gi25qb.png/1435723165045.jpg", "site_section": "http://www.afr.com/", "section_title": "Financial Review - Business, Finance and Investment News | afr.com", "url": "http://www.afr.com/news/policy/tax/pharmaceutical-companies-pay-just-85-million-on-8-billion-revenue-20150701-gi25qb", "country": "AU", "title": "Pharmaceutical companies pay just $85 million tax on $8 billion revenue", "performance_score": 0, "site": "afr.com", "participants_count": 1, "title_full": "Pharmaceutical companies pay just $85 million tax on $8 billion revenue | afr.com", "spam_score": 0.0, "site_type": "news", "published": "2015-07-01T11:50:00.000+03:00", "replies_count": 0, "uuid": "777d49bed415866ba6af6d006c1388ce27360177"}, "author": "Joanna Mather", "url": "http://www.afr.com/news/policy/tax/pharmaceutical-companies-pay-just-85-million-on-8-billion-revenue-20150701-gi25qb", "ord_in_thread": 0, "title": "Pharmaceutical companies pay just $85 million tax on $8 billion revenue", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Senator Sam Dastyari at a press conference after the inquiry. Daniel Munoz by Joanna Mather Nine of the biggest drug companies in the world had $8 billion in Australian revenue but paid just $85 million in tax last year, an inquiry has heard.\nDuring a public hearing in Sydney on Tuesday, members of a senate economics committee accused global pharmaceutical companies of shifting profits generated in Australia to low-tax jurisdictions offshore - the same charge levelled at technology companies.\n\"They have done what they can to drive up their costs, to make themselves as artificially unprofitable in Australia and make them more profitable in other jurisdictions to avoid paying tax here,\" Labor senator Sam Dastyari said.\nSenators quizzed the executives about their company's transfer pricing arrangements and whether Australian consumers are paying more as part of global schemes to minimise tax.\nThe Australian heads of AstraZeneca, Pfizer and GlaxoSmithKline told the inquiry they did not know what their companies' subsidiaries in other countries paid to import drugs.\nBut GSK Australia general manager Geoff McDonald said he was confident Australians paid \"very fair prices\" for pharmaceuticals.\nGreens senator Christine Milne said the companies set their prices according to what the market could bear, not what it actually cost to make and distribute the drugs.\nShe said there was some \"fast-footed avoidance going on\".\n ", "external_links": [], "published": "2015-07-01T11:50:00.000+03:00", "crawled": "2015-07-01T10:10:15.000+03:00", "highlightTitle": ""}